loader image
Friday, November 21, 2025
76 F
McAllen
- Advertisement -

Blood Cancers: Hidden Diseases with Many Treatments

Translate to Spanish or other 102 languages!

With blood cancers, there are no immediate visible signs, just the effects of the cancer in the blood system. Image for illustration purposes.

Mega Doctor News

- Advertisement -

By Hackensack Meridian Health (Mountainside Medical Center)

Newswise — MONTCLAIR, New Jersey (September 7, 2021) – When most people think about cancer, they tend to think of lumps and bumps, something visible they can see and touch. But with blood cancers, there are no immediate visible signs, just the effects of the cancer in the blood system. It may only be identified after a patient visits their doctor and describes symptoms like:

- Advertisement -
  • Fatigue
  • Pain and soreness
  • Swelling
  • Loss of function of an infected organ
John Conti, M.D., co-medical director of the cancer program at Mountainside Medical Center

“There are three main blood cancer types, each with its own variation: leukemia, lymphoma and multiple myeloma,” says John Conti, M.D., co-medical director of the cancer program at Hackensack Meridian Mountainside Medical Center. “These cancers usually start in a person’s bone marrow, which is where our red blood cells, white blood cells and platelets are formed,” says Dr. Conti.

When someone visits their doctor with the above symptoms, the doctor will often order a biopsy of the affected tissue or a bone marrow exam. The doctor may also order a PET/CT scan or a blood test to determine the stage of the cancer.

Unlike most solid tumors, blood cancers are very treatable with drugs and other substances, without the need for surgery, and in many cases, radiation. With the identification of the type of cancer, the physician may order:

  • Chemotherapy (treatment by chemical substance)
  • Immunotherapy (treatment by substances that create an immune response against the cancer)
  • Targeted therapy (using drugs to directly attack the cancer cells)

“Blood cancers are one of the first types of malignancies for which a cure was possible,” says Dr. Conti. “Although not all blood cancers are curable, almost all are treatable and many can go into remission for long periods of time.” The future continues to improve because numerous new drugs have been discovered over the past decade for this group of cancers. The landscape for treatment has never looked more promising than it does right now,” says Dr. Conti.

- Advertisement -

Patients at Mountainside Medical Center can receive quality cancer care close to home.  A multi-disciplinary team, including board-certified oncologists, oncology-experienced registered nurses, a nurse navigator and pharmacists educate and coordinate a personalized care plan for each patient.  Patients have access to additional resources including registered dietitians, licensed clinical social workers and spiritual support and guidance.

Through the hospital’s affiliation with John Theurer Cancer Center, our community has access to oncology sub-specialists, research and a variety of clinical trials.

September is Blood Cancer Awareness Month. Join Dr. Conti on Facebook on Monday, September 27, 2:30 p.m. as he answers common questions about blood cancers. Dr. Conti will take questions from the audience, or you may submit your questions in advance.  Visit facebook.com/Mountainsidemedicalcenter for more.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Paxton Secures $41.5M from Pfizer & Tris Pharma for Providing Adulterated Drugs to Children

Attorney General Ken Paxton has secured a $41.5 million settlement with Pfizer and Tris Pharma for allegedly providing adulterated pharmaceutical drugs to Texas children in violation of the Texas Health Care Program Fraud Prevention Act (“THFPA”).    

STHS’ South Texas Healthy Living Episode on Diabetes Awareness, Nov. 30th

The United States is experiencing a national health crisis as the incidence of diabetes continues to climb across the country.

Colorectal Cancer Screenings Remain Low For People Ages 45 To 49

UCLA research finds that fewer than 1 in 4 eligible younger adults completed colorectal cancer screenings after the United States Preventive Services Task Force (USPSTF) lowered the recommended screening age to 45 from 50.

DHR Health Encourages Early Detection with $99 Lung Cancer Screening Special Thru Dec. 31st

Lung cancer remains the leading cause of cancer death in the United States, accounting for about one in five cancer deaths nationwide. According to the American Cancer Society, an estimated 226,650 new cases of lung cancer will be diagnosed in 2025, and 124,730 people are expected to die from the disease. Each year, lung cancer claims more lives than colon, breast, and prostate cancers combined.
- Advertisement -
×